<img height="1" width="1" src="https://www.facebook.com/tr?id=841180246705289&amp;ev=PageView &amp;noscript=1">

We measure our impact by patient outcomes and the success of our partners. Learn More 

Innovation drives us

Our mission is to build the next generation of precision medicine.

It’s time for reality to catch up to the promise of machine learning in medicine. This means fully integrating molecular and clinical data for improved patient outcomes - in clinical trials and at the bedside. We are building the engineering layer to enact algorithms into clinical practice.

Get the right intervention, to the right patient, at the right time.

diagram-about-3c-1

Meet the team that makes it possible.

Andrew_Pucher

Andrew Pucher

Chief Executive Officer

LinkedIn
Anup_Radhakrishnan

Anup Radhakrishnan

Chief Financial Officer

LinkedIn
Duane_Williams-1

Duane Williams

Chief Commercial Officer

LinkedIn
Priya_Parameswaran

Priya Parameswaran

SVP, Strategy & Corporate Development

LinkedIn
Qingqing_Mao

Qingqing Mao

SVP, Data Science & Engineering

LinkedIn
Jana_Hoffman-1

Jana Hoffman

VP, Research & Writing

LinkedIn
Lisa_Chui

Lisa Chui

VP, Head of People

LinkedIn
Kristina_OConnell

Kristina O'Connell

VP, Corporate Affairs & Marketing

LinkedIn
Cindy_Wang

Cindy Wang

Sr. Director, Strategy & Corporate Development

LinkedIn
Andrew_Pucher

Andrew Pucher

Chief Executive Officer

LinkedIn

Andrew joins Dascena from Tilray, where he operated as Chief Corporate Development Officer through to the company’s announced sale for $1.4bn. During his time at Tilray, Andrew led the rapid global growth of the business, quadrupling revenue while driving the business to achieve profitability over the course of two years. Previously, Andrew was a Managing Director at Goldman Sachs, where he served as a senior leader within the investment bank’s Global Healthcare Group in New York, as well as Canadian Investment Banking franchise. Over the course of his career at Goldman Sachs, Andrew advised on more than $200 billion in M&A and financing transactions across the healthcare industry.

B.B.A., Simon Fraser University
J.D./M.B.A., York University
Anup_Radhakrishnan

Anup Radhakrishnan

Chief Financial Officer

LinkedIn

Duane_Williams-1

Duane Williams

Chief Commercial Officer

LinkedIn

Priya_Parameswaran

Priya Parameswaran

SVP, Strategy & Corporate Development

LinkedIn

Qingqing_Mao

Qingqing Mao

SVP, Data Science & Engineering

LinkedIn

Jana_Hoffman-1

Jana Hoffman

VP, Research & Writing

LinkedIn

Lisa_Chui

Lisa Chui

VP, Head of People

LinkedIn

Kristina_OConnell

Kristina O'Connell

VP, Corporate Affairs & Marketing

LinkedIn

Cindy_Wang

Cindy Wang

Sr. Director, Strategy & Corporate Development

LinkedIn

Our trusted advisors.

P.

P. Roy Vagelos, MD

Founding Investor

  • Chairman, Regeneron Pharmaceuticals. Inc.
  • Former Chairman & CEO, Merck & Co., Inc.
John

John C. Mather, PhD

  • Senior Scientist, NASA
  • Nobel Laureate, Physics (2006)
Mathai

Mathai Mammen, MD, PhD

  • Global Head of Research and Development, Janssen, Johnson & Johnson
Rick

Rick E. Winningham

  • Chairman & CEO, Theravance Biopharma, Inc.

Our board of directors.

Steve Goldman

Steve Goldman

Jamie Brush

Jamie Brush

Patrick Enright

Patrick Enright

Andrew_Pucher-1

Andrew Pucher

Ritankar Das

Ritankar Das

Interested in learning more?

Proud sponsor of Sepsis Alliance